BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 17210946)

  • 1. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
    Schrag D; Hanger M
    J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
    Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
    J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists.
    Newell S; Sanson-Fisher RW; Girgis A; Bonaventura A
    Cancer; 1998 Oct; 83(8):1640-51. PubMed ID: 9781960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communicating with patients about chemotherapy costs.
    de Lemos ML
    J Clin Oncol; 2007 May; 25(15):2142; author reply 2142. PubMed ID: 17513825
    [No Abstract]   [Full Text] [Related]  

  • 6. Australian oncologists' self-reported knowledge and attitudes about non-traditional therapies used by cancer patients.
    Newell S; Sanson-Fisher RW
    Med J Aust; 2000 Feb; 172(3):110-3. PubMed ID: 10735020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of physical activity among oncologists in the United States.
    Karvinen KH; DuBose KD; Carney B; Allison RR
    J Support Oncol; 2010; 8(1):35-41. PubMed ID: 20235422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer therapy costs influence treatment: a national survey of oncologists.
    Neumann PJ; Palmer JA; Nadler E; Fang C; Ubel P
    Health Aff (Millwood); 2010; 29(1):196-202. PubMed ID: 20048377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer.
    Spill GR; Hlubocky FJ; Daugherty CK
    PM R; 2012 Feb; 4(2):96-108. PubMed ID: 22373458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do oncologists believe new cancer drugs offer good value?
    Nadler E; Eckert B; Neumann PJ
    Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported practices and attitudes of US oncologists regarding off-protocol therapy.
    Peppercorn J; Burstein H; Miller FG; Winer E; Joffe S
    J Clin Oncol; 2008 Dec; 26(36):5994-6000. PubMed ID: 19029413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost issues in new disease-modifying treatments for advanced cancer: in-depth interviews with physicians.
    de Kort SJ; Kenny N; van Dijk P; Gevers S; Richel DJ; Willems DL
    Eur J Cancer; 2007 Sep; 43(13):1983-9. PubMed ID: 17616456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary survey of oncologists' perceptions of quality of life information.
    Bezjak A; Ng P; Taylor K; MacDonald K; Depetrillo AD
    Psychooncology; 1997 Jun; 6(2):107-13. PubMed ID: 9205968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan.
    Hyodo I; Eguchi K; Nishina T; Endo H; Tanimizu M; Mikami I; Takashima S; Imanishi J
    Cancer; 2003 Jun; 97(11):2861-8. PubMed ID: 12767101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
    Grunfeld EA; Ramirez AJ; Maher EJ; Peach D; Young T; Albery IP; Richards MA
    Br J Cancer; 2001 May; 84(9):1172-8. PubMed ID: 11336466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
    Chan A; Shih V; Chew L
    J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical oncologists' attitudes and practice in cancer pain management: a national survey.
    Breuer B; Fleishman SB; Cruciani RA; Portenoy RK
    J Clin Oncol; 2011 Dec; 29(36):4769-75. PubMed ID: 22084372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center.
    Fadul N; Elsayem A; Palmer JL; Del Fabbro E; Swint K; Li Z; Poulter V; Bruera E
    Cancer; 2009 May; 115(9):2013-21. PubMed ID: 19235253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care.
    Cherny NI; Catane R;
    Cancer; 2003 Dec; 98(11):2502-10. PubMed ID: 14635087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.